Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Income from Non-Controlling Interests (2020 - 2025)

Bioventus (BVS) has disclosed Income from Non-Controlling Interests for 6 consecutive years, with -$2.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Non-Controlling Interests fell 820.47% year-over-year to -$2.0 million, compared with a TTM value of $1.8 million through Sep 2025, up 114.88%, and an annual FY2024 reading of -$10.9 million, up 55.34% over the prior year.
  • Income from Non-Controlling Interests was -$2.0 million for Q4 2025 at Bioventus, down from $851000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $1.8 million in Q2 2025 and bottomed at -$28.2 million in Q4 2022.
  • Average Income from Non-Controlling Interests over 5 years is -$4.7 million, with a median of -$1.5 million recorded in 2023.
  • The sharpest move saw Income from Non-Controlling Interests tumbled 3006.54% in 2021, then surged 224.6% in 2025.
  • Year by year, Income from Non-Controlling Interests stood at -$1.6 million in 2021, then plummeted by 679.71% to -$12.5 million in 2022, then soared by 87.55% to -$1.6 million in 2023, then soared by 86.22% to -$215000.0 in 2024, then crashed by 820.47% to -$2.0 million in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for BVS at -$2.0 million in Q4 2025, $851000.0 in Q3 2025, and $1.8 million in Q2 2025.